You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Pharma & Healthcare

Global Oxytocic Pharmaceuticals Market Insights and Forecast to 2026

Available under the brand name of Pitocin, the drug oxytocin, which is derived from the peptide of the same name, is commonly used on women during childbirth in order to induce contractions. This can not only increase labor speeds and reduce the time taken for childbirth, but can also cease bleeding after delivery. It is almost always administered to a patient by injecting it into their vein or muscle.
The post-partum haemorrhage segment is expected to register high Y-o-Y growth during the forecast period and is projected to remain the dominant segment during the forecast period.
Market Analysis and Insights: Global Oxytocic Pharmaceuticals Market
Prior to COVID-19, the market for Oxytocic Pharmaceuticals was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of XX% during 2021–2026, whereas post-COVID-19 scenario, the market for Oxytocic Pharmaceuticals is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Oxytocic Pharmaceuticals market.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Oxytocic Pharmaceuticals market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Oxytocic Pharmaceuticals industry.
Global Oxytocic Pharmaceuticals Scope and Segment
Oxytocic Pharmaceuticals market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oxytocic Pharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
The following manufacturers are covered in this report:
Fresenius Kaci
Biofutura
Baxter
Pfizer
Ferring
Novartis
Teva
...
Oxytocic Pharmaceuticals Breakdown Data by Type
Natural Oxytocin
Synthetic Oxytocin Derivative
Oxytocic Pharmaceuticals Breakdown Data by Application
Abortion Induced Incomplete
Inevitable Abortion
Post-partum Haemorrhage
Labour Induction
Labour Arrest
Regional and Country-level Analysis
The Oxytocic Pharmaceuticals market is analysed and market size information is provided by regions (countries).
The key regions covered in the Oxytocic Pharmaceuticals market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Oxytocic Pharmaceuticals Market Share Analysis
1 Study Coverage
1.1 Oxytocic Pharmaceuticals Product Introduction
1.2 Market Segments
1.3 Key Oxytocic Pharmaceuticals Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Oxytocic Pharmaceuticals Market Size Growth Rate by Type
1.4.2 Natural Oxytocin
1.4.3 Synthetic Oxytocin Derivative
1.5 Market by Application
1.5.1 Global Oxytocic Pharmaceuticals Market Size Growth Rate by Application
1.5.2 Abortion Induced Incomplete
1.5.3 Inevitable Abortion
1.5.4 Post-partum Haemorrhage
1.5.5 Labour Induction
1.5.6 Labour Arrest
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Oxytocic Pharmaceuticals Market Size, Estimates and Forecasts
2.1.1 Global Oxytocic Pharmaceuticals Revenue 2015-2026
2.1.2 Global Oxytocic Pharmaceuticals Sales 2015-2026
2.2 Global Oxytocic Pharmaceuticals, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Oxytocic Pharmaceuticals Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Oxytocic Pharmaceuticals Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Oxytocic Pharmaceuticals Competitor Landscape by Players
3.1 Oxytocic Pharmaceuticals Sales by Manufacturers
3.1.1 Oxytocic Pharmaceuticals Sales by Manufacturers (2015-2020)
3.1.2 Oxytocic Pharmaceuticals Sales Market Share by Manufacturers (2015-2020)
3.2 Oxytocic Pharmaceuticals Revenue by Manufacturers
3.2.1 Oxytocic Pharmaceuticals Revenue by Manufacturers (2015-2020)
3.2.2 Oxytocic Pharmaceuticals Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Oxytocic Pharmaceuticals Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Oxytocic Pharmaceuticals Revenue in 2019
3.2.5 Global Oxytocic Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Oxytocic Pharmaceuticals Price by Manufacturers
3.4 Oxytocic Pharmaceuticals Manufacturing Base Distribution, Product Types
3.4.1 Oxytocic Pharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oxytocic Pharmaceuticals Product Type
3.4.3 Date of International Manufacturers Enter into Oxytocic Pharmaceuticals Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Oxytocic Pharmaceuticals Market Size by Type (2015-2020)
4.1.1 Global Oxytocic Pharmaceuticals Sales by Type (2015-2020)
4.1.2 Global Oxytocic Pharmaceuticals Revenue by Type (2015-2020)
4.1.3 Oxytocic Pharmaceuticals Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Oxytocic Pharmaceuticals Market Size Forecast by Type (2021-2026)
4.2.1 Global Oxytocic Pharmaceuticals Sales Forecast by Type (2021-2026)
4.2.2 Global Oxytocic Pharmaceuticals Revenue Forecast by Type (2021-2026)
4.2.3 Oxytocic Pharmaceuticals Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Oxytocic Pharmaceuticals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Oxytocic Pharmaceuticals Market Size by Application (2015-2020)
5.1.1 Global Oxytocic Pharmaceuticals Sales by Application (2015-2020)
5.1.2 Global Oxytocic Pharmaceuticals Revenue by Application (2015-2020)
5.1.3 Oxytocic Pharmaceuticals Price by Application (2015-2020)
5.2 Oxytocic Pharmaceuticals Market Size Forecast by Application (2021-2026)
5.2.1 Global Oxytocic Pharmaceuticals Sales Forecast by Application (2021-2026)
5.2.2 Global Oxytocic Pharmaceuticals Revenue Forecast by Application (2021-2026)
5.2.3 Global Oxytocic Pharmaceuticals Price Forecast by Application (2021-2026)

6 North America
6.1 North America Oxytocic Pharmaceuticals by Country
6.1.1 North America Oxytocic Pharmaceuticals Sales by Country
6.1.2 North America Oxytocic Pharmaceuticals Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Oxytocic Pharmaceuticals Market Facts & Figures by Type
6.3 North America Oxytocic Pharmaceuticals Market Facts & Figures by Application

7 Europe
7.1 Europe Oxytocic Pharmaceuticals by Country
7.1.1 Europe Oxytocic Pharmaceuticals Sales by Country
7.1.2 Europe Oxytocic Pharmaceuticals Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Oxytocic Pharmaceuticals Market Facts & Figures by Type
7.3 Europe Oxytocic Pharmaceuticals Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Oxytocic Pharmaceuticals by Region
8.1.1 Asia Pacific Oxytocic Pharmaceuticals Sales by Region
8.1.2 Asia Pacific Oxytocic Pharmaceuticals Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Oxytocic Pharmaceuticals Market Facts & Figures by Type
8.3 Asia Pacific Oxytocic Pharmaceuticals Market Facts & Figures by Application

9 Latin America
9.1 Latin America Oxytocic Pharmaceuticals by Country
9.1.1 Latin America Oxytocic Pharmaceuticals Sales by Country
9.1.2 Latin America Oxytocic Pharmaceuticals Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Oxytocic Pharmaceuticals Market Facts & Figures by Type
9.3 Central & South America Oxytocic Pharmaceuticals Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Oxytocic Pharmaceuticals by Country
10.1.1 Middle East and Africa Oxytocic Pharmaceuticals Sales by Country
10.1.2 Middle East and Africa Oxytocic Pharmaceuticals Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Oxytocic Pharmaceuticals Market Facts & Figures by Type
10.3 Middle East and Africa Oxytocic Pharmaceuticals Market Facts & Figures by Application

11 Company Profiles
11.1 Fresenius Kaci
11.1.1 Fresenius Kaci Corporation Information
11.1.2 Fresenius Kaci Description and Business Overview
11.1.3 Fresenius Kaci Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Fresenius Kaci Oxytocic Pharmaceuticals Products Offered
11.1.5 Fresenius Kaci Related Developments
11.2 Biofutura
11.2.1 Biofutura Corporation Information
11.2.2 Biofutura Description and Business Overview
11.2.3 Biofutura Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Biofutura Oxytocic Pharmaceuticals Products Offered
11.2.5 Biofutura Related Developments
11.3 Baxter
11.3.1 Baxter Corporation Information
11.3.2 Baxter Description and Business Overview
11.3.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Baxter Oxytocic Pharmaceuticals Products Offered
11.3.5 Baxter Related Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Description and Business Overview
11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer Oxytocic Pharmaceuticals Products Offered
11.4.5 Pfizer Related Developments
11.5 Ferring
11.5.1 Ferring Corporation Information
11.5.2 Ferring Description and Business Overview
11.5.3 Ferring Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Ferring Oxytocic Pharmaceuticals Products Offered
11.5.5 Ferring Related Developments
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Description and Business Overview
11.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Novartis Oxytocic Pharmaceuticals Products Offered
11.6.5 Novartis Related Developments
11.7 Teva
11.7.1 Teva Corporation Information
11.7.2 Teva Description and Business Overview
11.7.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Teva Oxytocic Pharmaceuticals Products Offered
11.7.5 Teva Related Developments
11.1 Fresenius Kaci
11.1.1 Fresenius Kaci Corporation Information
11.1.2 Fresenius Kaci Description and Business Overview
11.1.3 Fresenius Kaci Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Fresenius Kaci Oxytocic Pharmaceuticals Products Offered
11.1.5 Fresenius Kaci Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Oxytocic Pharmaceuticals Market Estimates and Projections by Region
12.1.1 Global Oxytocic Pharmaceuticals Sales Forecast by Regions 2021-2026
12.1.2 Global Oxytocic Pharmaceuticals Revenue Forecast by Regions 2021-2026
12.2 North America Oxytocic Pharmaceuticals Market Size Forecast (2021-2026)
12.2.1 North America: Oxytocic Pharmaceuticals Sales Forecast (2021-2026)
12.2.2 North America: Oxytocic Pharmaceuticals Revenue Forecast (2021-2026)
12.2.3 North America: Oxytocic Pharmaceuticals Market Size Forecast by Country (2021-2026)
12.3 Europe Oxytocic Pharmaceuticals Market Size Forecast (2021-2026)
12.3.1 Europe: Oxytocic Pharmaceuticals Sales Forecast (2021-2026)
12.3.2 Europe: Oxytocic Pharmaceuticals Revenue Forecast (2021-2026)
12.3.3 Europe: Oxytocic Pharmaceuticals Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Oxytocic Pharmaceuticals Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Oxytocic Pharmaceuticals Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Oxytocic Pharmaceuticals Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Oxytocic Pharmaceuticals Market Size Forecast by Region (2021-2026)
12.5 Latin America Oxytocic Pharmaceuticals Market Size Forecast (2021-2026)
12.5.1 Latin America: Oxytocic Pharmaceuticals Sales Forecast (2021-2026)
12.5.2 Latin America: Oxytocic Pharmaceuticals Revenue Forecast (2021-2026)
12.5.3 Latin America: Oxytocic Pharmaceuticals Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Oxytocic Pharmaceuticals Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Oxytocic Pharmaceuticals Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Oxytocic Pharmaceuticals Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Oxytocic Pharmaceuticals Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Oxytocic Pharmaceuticals Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oxytocic Pharmaceuticals Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
  • FORMAT: PDF
  • PUBLISHED DATE: Jun, 2020
  • NO OF PAGES: 126